Tag Archives: outsourcing

Biopharma's Top Offshore Destinations

Biopharmaceutical manufacturing is following the general pharmaceutical market trend toward global expansion. BioPlan Associates’ 11th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production identifies the markets best poised to profit from the internationalization of the outsourcing, finding that emerging markets such as China and India are among top potential destinations for both US and Western […]
Posted in Emerging Markets, Global, Guest Blog | Also tagged , | Leave a comment

Sunny Outlook for Outsourcing

Early-stage and mid-size bio/pharmaceutical companies have enjoyed an embarrassment of riches over the past 18 months. The window for initial public offerings (IPOs) re-opened, at least for a while. Global bio/pharmaceutical companies continued their frenzied pace of partnering and acquisition activity, and venture capital spiked up as the prospects improved for rich exits. The results […]
Posted in Global, Guest Blog | Also tagged , | Leave a comment

Sponsor–CMO Relationships: Critical Issues

Eric Langer assesses the results of a recent survey of what biopharm companies want from CMOs. Contract manufacturing organizations (CMOs) should have the technical expertise to be considered by clients for partnerships. It’s no longer enough for them to lay claim to technology, regulatory compliance, and IP protection expertise, as these increasingly become non-negotiable issues, according […]
Posted in Biotech | Also tagged , | Leave a comment

Cost Cutting No Longer Main Driver of Outsourcing

Biopharmaceutical companies have traditionally considered outsourcing as a way to control costs and manage their internal resources to make the core activities left in-house more efficient. But in recent years, surveys of biopharmaceutical manufacturers by BioPlan Associates have shown that cost cutting is, by far, not the primary reason companies outsource anymore. In fact, this […]
Posted in Strategy | Also tagged , | Leave a comment

The CMO Industry: Stuck in Neutral

The contract manufacturing industry isn’t gaining market share. Could it be that the CMO business model is out of synch with the current realities of the bio/pharmaceutical industry? Jim Miller reports. PharmSource recently completed an analysis of the dose CMO industry’s share of new FDA approvals (1). Our research found that of the 90 new […]
Posted in Guest Blog, Strategy | Also tagged , | Leave a comment
  • Categories

  • Meta